# Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

> **NCT04913311** · — · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 150 (estimated)

## Conditions studied

- Lung Non-Small Cell Carcinoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bronchoscopy with Bronchoalveolar Lavage
- **OTHER:** Chemoradiotherapy
- **PROCEDURE:** Computed Tomography
- **OTHER:** Diagnostic Laboratory Biomarker Analysis
- **DRUG:** Immune Checkpoint Inhibitor
- **PROCEDURE:** Nasal Wash and Collection
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Spirometry

## Key facts

- **NCT ID:** NCT04913311
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-21
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-02-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04913311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04913311, "Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT04913311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*